Related Experiment Video
Updated: May 28, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis
Maryam Gul1,2, Sajid Ali3, Abdul Rehman1
1Department of Microbiology, Kohat University of Science and Technology, Kohat 26000, Khyber Pakhtunkhwa, Pakistan.
Genomic surveillance of multidrug-resistant tuberculosis (MDR-TB) in Pakistan identified novel mutations in key genes like rpoB, contributing to first-line drug resistance. Understanding these region-specific genetic profiles is crucial for effective TB control.
Area of Science:
- Genomics
- Microbiology
- Public Health
Background:
- Tuberculosis (TB) drug resistance, particularly multidrug-resistant TB (MDR-TB), poses a significant global health challenge.
- High-burden settings like Pakistan face complex control efforts due to resistance to first-line drugs, often linked to mutations in genes such as rpoB, inhA, katG, embA, embB, embC, and pncA.
- Emerging region-specific variants necessitate integrating genomic surveillance into routine TB diagnostics and control programs.
Purpose of the Study:
- To identify the spectrum of mutations associated with first-line anti-tuberculosis drug resistance in MDR-TB isolates from Khyber Pakhtunkhwa, Pakistan.
- To investigate the genetic diversity and phylogenetic relationships among these isolates.
Main Methods:
- Whole-genome sequencing of 16 clinical Mycobacterium tuberculosis isolates (12 MDR, 4 drug-susceptible).
- Identification of resistance-associated mutations in key genes (rpoB, inhA, katG, embA, embB, embC, pncA).
- Interpretation of variants using the WHO mutation catalogue and phylogenetic analysis via the BV-BRC platform.
Main Results:
- 76 distinct variants were found in rpoB, including known mutations and a novel Ser431Phe substitution potentially conferring high-level rifampicin resistance.
- 24 and 27 mutations were identified in katG and inhA, respectively, including Ser315Thr and Ala114Glu associated with isoniazid resistance.
- Mutations in embA and embB linked to ethambutol resistance; phylogenetic analysis showed genetic diversity and local transmission of MDR-TB.
Conclusions:
- The genetic landscape of drug resistance in Mycobacterium tuberculosis is dynamic in endemic regions.
- Integrating region-specific mutation profiles into molecular diagnostics is vital for early detection and guiding individualized treatment.
- Enhanced understanding of local resistance patterns strengthens strategies to control MDR-TB transmission.
Related Concept Videos
Development of Antibiotic Resistance
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Clinical Significance of Antibiotic Resistance
Treatment Resistant Cancers
Mechanism of Antibiotic Resistance in MRSA
Modern Molecular Taxonomy
